V1-Cal hydrogelation enhances its effects on ventricular remodeling reduction and cardiac function improvement post myocardial infarction
Myocardial infarction (MI) is a major cause of disability and mortality worldwide. A cell permeable peptide V1-Cal has shown remarkable therapeutic effects on ML However, using V1-Cal to improve long-term cardiac function after MI is presently limited by its short half-life. Herein, we co-assembled...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Chemical engineering journal (Lausanne, Switzerland : 1996). - 1999. - 433(2022), Pt 1 vom: 01. Apr.
|
|---|
| 1. Verfasser: |
Wang, Bin
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Wu, Chengfan,
He, Shufang,
Wang, Yaguang,
Wang, Di,
Tao, Hui,
Wang, Chenchen,
Pang, Xiaoxi,
Li, Fei,
Yuan, Yue,
Gross, Eric R,
Liang, Gaolin,
Zhang, Ye |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2022
|
|---|
| Zugriff auf das übergeordnete Werk: | Chemical engineering journal (Lausanne, Switzerland : 1996)
|
|---|
| Schlagworte: | Journal Article
Myocardial infarction
Supramolecular hydrogel
Sustained release
TRPV1
V1-Cal |
|---|